Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 95701-95750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04134923
Imaging Biomarkers in Preclinical and Symptomatic AD
N/ARecruiting
375 participants
Started: Jun 8, 2021 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT04943653
Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis
PHASE1/PHASE2Recruiting
61 participants
Started: Jun 8, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05106699
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NARecruiting
54 participants
Started: Jun 8, 2021 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04647916
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
PHASE2Active, not recruiting
44 participants
Started: Jun 8, 2021 · Completed: Dec 31, 2028
5 conditions3 sponsors296 locations
NCT04806958
The PulsePoint Study
NARecruiting
340 participants
Started: Jun 8, 2021 · Completed: Jun 30, 2026
4 conditions9 sponsors3 locations
NCT04923477
Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms
NARecruiting
60 participants
Started: Jun 8, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04511039
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
PHASE1Recruiting
45 participants
Started: Jun 8, 2021 · Completed: Apr 1, 2027
29 conditions2 sponsors1 location
NCT06695078
Nutrition in Paediatric Critical Care
N/ARecruiting
200 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2027
3 conditions1 sponsor11 locations
NCT04481113
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE1Active, not recruiting
8 participants
Started: Jun 7, 2021 · Completed: Dec 30, 2025
20 conditions4 sponsors1 location
NCT04596514
Resuscitative Endovascular Balloon Occlusion of the Aorta in Non-traumatic Out of Hospital Cardiac Arrest
NAActive, not recruiting
200 participants
Started: Jun 7, 2021 · Completed: Jul 31, 2026
1 condition2 sponsors11 locations
NCT05044767
Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty
N/ARecruiting
4,500 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2032
1 condition1 sponsor13 locations
NCT04815187
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
PHASE4Active, not recruiting
39 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors2 locations
NCT04373122
REBOA in Out-of-hospital Cardiac Arrest
NARecruiting
15 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04165109
Trial-Ready Cohort-Down Syndrome (TRC-DS)
N/ARecruiting
450 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2027
3 conditions4 sponsors20 locations
NCT05003739
Hip Arthroplasty with Logica Mirror Femoral Stem
N/ARecruiting
62 participants
Started: Jun 7, 2021 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT04934839
Instrumental Analysis of Walking in People With Osseointegrated Prostheses for Lower Extremity Amputation: Comparative Evaluation With Traditional Socket Prostheses
NARecruiting
8 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2024
1 condition2 sponsors2 locations
NCT04772937
Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia
NARecruiting
206 participants
Started: Jun 7, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04837222
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
N/AActive, not recruiting
1,000 participants
Started: Jun 7, 2021 · Completed: Jun 19, 2026
1 condition1 sponsor32 locations
NCT04853342
To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
PHASE3Recruiting
318 participants
Started: Jun 7, 2021 · Completed: Jan 31, 2030
1 condition1 sponsor1 location
NCT04922736
Patient Reported Outcomes with UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
NAEnrolling by invitation
30 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04872166
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
PHASE1Recruiting
112 participants
Started: Jun 7, 2021 · Completed: May 31, 2027
2 conditions1 sponsor6 locations
NCT04437914
Accuracy of Cardiac Arrhythmias and Conduction Disorders Diagnosis Using a Smartwatch
N/ARecruiting
110 participants
Started: Jun 7, 2021 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT04709276
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
PHASE2Active, not recruiting
41 participants
Started: Jun 7, 2021 · Completed: Aug 31, 2028
2 conditions2 sponsors3 locations
NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3Recruiting
1,670 participants
Started: Jun 7, 2021 · Completed: Jul 31, 2041
1 condition2 sponsors823 locations
NCT04879628
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
PHASE2Active, not recruiting
129 participants
Started: Jun 7, 2021 · Completed: Aug 23, 2027
1 condition1 sponsor37 locations
NCT04875195
A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)
PHASE2Active, not recruiting
66 participants
Started: Jun 7, 2021 · Completed: Oct 13, 2025
2 conditions1 sponsor27 locations
NCT04931368
OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma
PHASE3Recruiting
326 participants
Started: Jun 7, 2021 · Completed: Nov 30, 2028
1 condition3 sponsors1 location
NCT05305144
Retinal, Cerebral and Vascular Precursor Markers of Cerebral Small Vessel Disease.
NAActive, not recruiting
206 participants
Started: Jun 7, 2021 · Completed: Jun 7, 2024
1 condition2 sponsors1 location
NCT04765592
Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)
NAActive, not recruiting
88 participants
Started: Jun 7, 2021 · Completed: Feb 5, 2029
1 condition1 sponsor23 locations
NCT04915482
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
PHASE2/PHASE3Recruiting
94 participants
Started: Jun 6, 2021 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT04889079
Assessing Adolescent Use of Nexplanon Over Time
N/AActive, not recruiting
255 participants
Started: Jun 6, 2021 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05411055
Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium (Ozaki Procedure)
N/AActive, not recruiting
60 participants
Started: Jun 6, 2021 · Completed: Jun 6, 2027
1 condition1 sponsor1 location
NCT05109468
Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment
N/AActive, not recruiting
46 participants
Started: Jun 6, 2021 · Completed: Jun 6, 2025
5 conditions1 sponsor1 location
NCT06277388
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
N/ARecruiting
237 participants
Started: Jun 5, 2021 · Completed: Jun 5, 2025
2 conditions1 sponsor1 location
NCT04910464
Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
PHASE3Recruiting
80 participants
Started: Jun 5, 2021 · Completed: Jan 30, 2027
1 condition1 sponsor1 location
NCT03701581
4-aminopyridine Treatment for Nerve Injury
PHASE2/PHASE3Recruiting
70 participants
Started: Jun 5, 2021 · Completed: Dec 31, 2028
2 conditions1 sponsor2 locations
NCT04621357
Influence of Cerebral Oedema in Intracerebral Haemorrhage
NARecruiting
500 participants
Started: Jun 4, 2021 · Completed: Jun 30, 2025
2 conditions3 sponsors1 location
NCT05203250
Longitudinal Registry Including Patients Treated With Heavy Particles
N/ARecruiting
3,000 participants
Started: Jun 4, 2021 · Completed: Jun 4, 2071
6 conditions1 sponsor1 location
NCT04664192
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
N/ARecruiting
100 participants
Started: Jun 4, 2021 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT04764357
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
NARecruiting
40 participants
Started: Jun 4, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06332976
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
N/ARecruiting
450 participants
Started: Jun 4, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04779554
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
PHASE2Recruiting
100 participants
Started: Jun 4, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT04701918
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
PHASE2Recruiting
30 participants
Started: Jun 4, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT04505371
Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
NAActive, not recruiting
226 participants
Started: Jun 4, 2021 · Completed: Feb 28, 2026
3 conditions5 sponsors1 location
NCT04573881
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)
NAActive, not recruiting
24 participants
Started: Jun 4, 2021 · Completed: Aug 31, 2027
3 conditions1 sponsor6 locations
NCT04352400
Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)
PHASE2/PHASE3Recruiting
256 participants
Started: Jun 4, 2021 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT04738942
A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
PHASE3Active, not recruiting
57 participants
Started: Jun 4, 2021 · Completed: Nov 30, 2027
2 conditions1 sponsor20 locations
NCT04938232
Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
PHASE2Active, not recruiting
13 participants
Started: Jun 4, 2021 · Completed: Aug 1, 2026
3 conditions2 sponsors4 locations
NCT04988620
Cold Stored Whole Blood in Cardiothoracic Surgery
NARecruiting
80 participants
Started: Jun 4, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04803877
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
PHASE2Active, not recruiting
48 participants
Started: Jun 4, 2021 · Completed: Jun 30, 2026
4 conditions1 sponsor8 locations